MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis

Abstract

We present a new update to MetaboAnalyst (version 4.0) for comprehensive metabolomic data analysis, interpretation, and integration with other omics data. Since the last major update in 2015, MetaboAnalyst has continued to evolve based on user feedback and technological advancements in the field. For this year's update, four new key features have been added to MetaboAnalyst 4.0, including: (1) real-time R command tracking and display coupled with the release of a companion MetaboAnalystR package; (2) a MS Peaks to Pathways module for prediction of pathway activity from untargeted mass spectral data using the mummichog algorithm; (3) a Biomarker Meta-analysis module for robust biomarker identification through the combination of multiple metabolomic datasets and (4) a Network Explorer module for integrative analysis of metabolomics, metagenomics, and/or transcriptomics data. The user interface of MetaboAnalyst 4.0 has been reengineered to provide a more modern look and feel, as well as to give more space and flexibility to introduce new functions. The underlying knowledgebases (compound libraries, metabolite sets, and metabolic pathways) have also been updated based on the latest data from the Human Metabolome Database (HMDB). A Docker image of MetaboAnalyst is also available to facilitate download and local installation of MetaboAnalyst. MetaboAnalyst 4.0 is freely available at http://metaboanalyst.ca.

Deciphering the Human Gut Microbiome of Urolithin Metabotypes: Association with Enterotypes and Potential Cardiometabolic Health Implications

“…Spearman's rank correlation was applied to explore the link between lipid profile and the bacterial genera. Heat map of data was performed using the free tool Metaboanalyst . Statistical significance was set at * p < 0.05, ** p < 0.01, and *** p < 0.001.…”

Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor‐B cell acute lymphoblastic leukemia

“…Probabilistic quotient normalization was performed before statistical analysis 30 . Pathway analysis was performed with MetaboAnalyst on confirmed features 31 …”

Quantitative determination of human IgA subclasses and their Fc‐glycosylation patterns in plasma by using a peptide analogue internal standard and ultra‐high‐performance liquid chromatography/triple quadrupole mass spectrometry

“…Peak areas of IgA1/2 N340/327 and IgA1/2 N144/131 glycopeptides were normalized to total IgA concentrations, and peak areas of IgA2 N205 glycopeptides were normalized to IgA2 concentrations. Normalized glycopeptide responses were used to generate a sparse partial least‐squares discrimination analysis (sPLS‐DA) score plot to check if there is a profile difference between groups by using the MetaboAnalyst 4.0 Statistical Analysis tool …”